top of page
C
Calciphylaxis
Etiology: necrosis of skin + fatty tissue, typically in ESRD pts; can occur in those with high or normal levels of serum calcium + phosphate
At risk: females, obesity, immunosuppressed
Appearance:
- begins as surface purple retiform purpura
- then turns black in the center as a stellate shaped purpura
then turns into dry gangrene + ulcerates
Tx: normalize calcium + phosphate levels associated with renal failure; IV infusions of sodium thiosulfate
Carbuncle
Etiology: multiple bacterial folliculitis (furuncles/boils); typically S. aureus
- mnemonic: "multiple furuncles fit in a CAR"
Appearance: erythematous pustules surrounding a hair follicle
Ass. with: Neurofibromatosis, McCune-Albright syndrome, Fanconi Anemia
Tx: antibacterial soap, oral abx
![]() | ![]() |
|---|---|
![]() | ![]() |
Carney Complex
Etiology: inactivating mutation in PRKAR1A
Inheritance: AD
Appearance: hyperpigmented macules
Location: labial, perioral, periorbital, anogenital
Ass. with: cardiac myxoma, skin myxomas, lentiginosis, pituitary adenomas, testicular tumors, primary pigmented nodular adrenocortical disease




1/7
Carrión Disease (Verruga peruana / Peruvian wart)
Etiology: Bartonella bacilliformis
At risk: South Americans
Appearance: eruption of red to purple nodules
Tx: abx
Cellulitis
Etiology: S. pyogenes, S. aureus (often from a break in skin from trauma, infix, or recent surgery)
Appearance: poorly-demarcated erythematous edematous plaque; typically unilateral
At risk: middle age + older
Location: lower extremities
Tx: oral cephalexin or IV cefazolin

Central Centrifugal Cicatricial Alopecia (CCCA)
MC scarring hair loss
Etiology: unknown, multifactorial
At risk: African American females
Location: vertex, frontal hair line
Appearance: shiny scalp with follicular dropout
Common sx: itchy scalp, burning sensation
Tx: topical or intralesional CS, tacrolimus, Doxy
![]() | ![]() |
|---|---|
![]() | ![]() |
![]() |
Chancroid
Etiology: H. ducreyi
Appearance: one or more erythematous papules that quickly evolve into pustules and become larger until they break down into an ulcer
Sx: extremely painful ulcer that bleeds easily
Tx: azithromycin




1/4
Cherry Angioma
Etiology: aging; sometimes associated with somatic missense mutations in GNAQ and GNA11 (Q209H) genes
Appearance: erythematous to blue or purple papule or nodule
Location: trunk
Tx: ED, laser, cryo, shave excision
Chillblains
Etiology: tender and/or itchy bumps following exposure to damp, cold, non-freezing conditions causing constriction of small arteries and veins but a protective reflex intermittently dilates
At risk: young to middle-aged adults, females
Location: hands, feet, ears
Tx: avoid cold, wet temps, topical nitroglycerine
Prog: spontaneously regress in 1-3 weeks
![]() | ![]() | ![]() |
|---|---|---|
![]() | ![]() | ![]() |
![]() | ![]() | ![]() |
![]() | ![]() | ![]() |
![]() |
Chloasma / Melasma
Etiology: overproduction of melanin by melanocytes; triggered by sun exposure, hormones, medications, ass. with family hx
Appearance: light-to-dark brown macules or patches with irregular borders
Location: bilateral cheeks
At risk: pregnancy, females
Tx: hydroquinone, tretinoin
Coccidiomycosis / Valley Fever
Etiology: allergic reaction to Coccidioides immitis
Appearance: erythema nodosum or erythema multiforme




1/5
Comedones: Open + Closed
Etiology: cells lining the sebaceous duct proliferate and there is increased sebum production causing debris blockage of the sebaceous duct and hair follicle
Appearance:
-
open = grey, brown, black papules; keratinous contents can be expressed
-
closed = skin colored papules
Tx: benzoyl peroxide, azelaic acid, salicylic acid, tretinoin, adapelene

Closed comedones

Closed comedones

Closed comedones

Closed comedones

Open comedones

Open comedones

Open comedones
Conradi-Hünermann-Happle syndrome
Characterized by: skeletal abnormalities, skin lesions following Blaschko's lines, cataracts
Inheritance: XLD (females>)
Appearance: linear or whorled hyperkeratotic scales following the lines of Blaschko, follicular atrophoderma, pigmentary changes, and sometimes pustular lesions
![]() | ![]() |
|---|---|
![]() | ![]() |
![]() | ![]() |
![]() |
Cowden Syndrome
Etiology: mutation in PTEN
Inheritance: AD
Appearance: skin colored to yellow-brown, flat topped warty papules
Location: central face surrounding eyes, nose, mouth
Tx: 5-FU, oral retinoids












Crusted Scabies / Norwegian Scabies
Etiology: Sarcoptes scabiei var hominis
Appearance: poorly defined erythematous patches that develop into thick scaly plaques
At risk: immunocompromised, elderly, disabled or debilitated, HIV patients
Location: between the fingers, under the nails, or diffusely over palms and soles, knees, and elbows
Tx: oral ivermectin, topical insecticides
![]() | ![]() |
|---|---|
![]() | ![]() |
![]() |
Cushing Disease
Etiology: increased ACTH = increased cortisol = decreased collagen synthesis = BV rupture easier
Appearance: purple striae (stretch marks)
Location: abdomen
Cutaneous Anthrax
Etiology: Bacillus anthracis
Appearance: papule with surrounding vesicles that progress to an ulcer with black eschar
Sx: painless
Tx: doxy
Cutaneous Horn
Etiology: underlying lesions are seborrheic keratosis, viral warts (due to HPV), actinic keratosis, or well-differentiated SCC (50/50 benign vs premalignant or malignant)
Appearance: straight or curved, hard, yellow-brown projection from the skin
At risk: 60+ yo
Location: sun-exposed areas
Tx: excise
Cutaneous Leishmaniasis
Etiology: Leishmania
Appearance: initial lesion appears 2 weeks - 2 mo after sandfly bite and is a small red papule, which gradually enlarges up to 2 cm in diameter and forms an ulcerated nodule with raised border (volcano sign)
Location: exposed skin, esp. face + extremities
At risk: living or traveling through areas where sandflies and Leishmania species are endemic
Cutaneous Neurofibroma
Etiology: can be caused by NF1 gene mutation
Inheritance: AD
Appearance: circumscribed, soft button-like brown, pink, or skin colored nodules with a soft or firm consistency
Location: trunk
Tx: no cure; selumetinib may offer hope in reducing the size of plexiform neurofibromas




1/10
bottom of page







































































































































































































